Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Summit Therapeutics (SMMT) Return on Invested Capital (2019 - 2021)

Summit Therapeutics filings provide 3 years of Return on Invested Capital readings, the most recent being 0.01% for Q3 2021.

  • Quarterly Return on Invested Capital changed 0.0% to 0.01% in Q3 2021 from the year-ago period, while the trailing twelve-month figure was 0.01% through Sep 2021, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2020, 0.0% changed from the prior year.
  • Return on Invested Capital hit 0.01% in Q3 2021 for Summit Therapeutics, up from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q1 2019 and bottomed at 0.04% in Q3 2019.
  • Average Return on Invested Capital over 3 years is 0.01%, with a median of 0.01% recorded in 2020.
  • The largest annual shift saw Return on Invested Capital dropped -4bps in 2020 before it rose 3bps in 2021.
  • Summit Therapeutics' Return on Invested Capital stood at 0.02% in 2019, then surged by 53bps to 0.01% in 2020, then increased by 27bps to 0.01% in 2021.
  • Per Business Quant, the three most recent readings for SMMT's Return on Invested Capital are 0.01% (Q3 2021), 0.01% (Q2 2021), and 0.01% (Q1 2021).